Objectives. The purpose of this study was to assess the relationships between stigma and shame associated with seeking treatment for sexually transmitted diseases (STDs) and undergoing testing for gonorrhea and HIV.

Methods. Participants were 847 males and 1126 females (mean age: 24.9 years) in 7 cities. Two scales assessed STD-related stigma and STD-related shame.

Results. Rates of stigma and shame were higher among participants without a gonorrhea test in the past year and among those without an HIV test. Sex, age, health service use, previous suspicion of gonorrhea, and low levels of stigma were independently associated with gonorrhea testing. Age, enrollment site, use of health services, gonorrhea testing, and low levels of stigma were independently associated with HIV testing.

Conclusions. Shame is part of the experience of seeking STD-related care, but stigma may be a more powerful barrier to obtaining such care. (Am J Public Health. 2002;92:378–381)

Stigma and shame associated with sexually transmitted diseases (STDs) and HIV infection are important barriers to appropriate diagnostic and treatment services. For example, in one study, 59% of men who had never been tested for HIV cited fear of negative social consequences as an important reason for not seeking testing.1 Stigma may influence pregnant women's refusal to be tested for HIV despite the benefits of treatment during pregnancy.2,3 Similarly, 44% of the high-risk males in a study by Woods et al. stated that if name-based reporting were implemented, they would not accept HIV testing, and they maintained this intention even after being told of the potential benefits of such reporting.4 A recent Institute of Medicine report identified stigma as a key element of the “hidden epidemic” of STDs in the United States.5

Stigma and shame are related but distinct constructs. Stigma is defined as an attribute or label that sets a person apart from others and links the labeled person to undesirable characteristics.6 Stigma related to AIDS has been defined as “the prejudice, discounting, discrediting, and discrimination that are directed at people perceived to have AIDS.”7

An additional implicit characteristic of stigma is that it represents socially shared knowledge understood even by the targets of the stigmatizing attitudes and behaviors.8 Thus, shame can be an internalized reaction to stigma.6,9 Shame is defined as a negative emotion elicited when a person experiences failure in relation to personal or social standards, feels responsible for this failure, and believes that the failure reflects selfinadequacy rather than inappropriate behavior. The term “self-stigmatization” is sometimes used synonymously with shame to reflect a person's acceptance of the negative aspects of a stigma.7 Shame is clearly distinguishable, however, from the related negative affect states of guilt and embarrassment.10

The purpose of this research was to examine relationships of stigma and shame with 2 types of STD-related care: receipt of a test for gonorrhea during the past year and receipt of at least 1 HIV test in the previous year. Receipt of gonorrhea or HIV screening requires care seeking by individuals and communication with clinicians that may be affected by stigma, shame, or both. In the case of both gonorrhea and HIV, screening provides an opportunity for risk-reduction interventions among those who are not infected. Among those found to be infected, effective treatment and control strategies can reduce the risk of sequelae and limit transmission to others.11,12 STD/HIV-related care could therefore be improved through a better understanding of factors such as stigma or shame that may act as barriers to appropriate screening.

Respondents

Data were collected in 1998 as part of the Gonorrhea Community Action Project, a multisite research program designed to evaluate STD-related care from the multiple perspectives of clients, providers, and health care systems. Participating sites included Prince George's County, Maryland; Denver, Colo; Los Angeles, Calif; Indianapolis, Ind; St. Louis, Mo; Central Harlem, NY; and Birmingham, Ala.

Respondents were recruited from clinics, from community-based organizations, and through street intercept in each of the 7 locations. Clinic sites were mainly primary care settings but also included STD clinics. The street intercept and community-based organization recruitment strategies targeted constituencies at high risk for gonorrhea and HIV. Administrators at each research site were asked to interview an equal number of subjects from each recruitment source. All information was collected via face-to-face interviews requiring 20 to 40 minutes to complete. No effort was made to match interviewers and respondents in regard to sex, race/ethnicity, age, or sexual preference.

The study protocol was approved by the institutional review boards of the participating sites as well as the institutional review board of the Centers for Disease Control and Prevention. Written informed consent was obtained from each participant.

Measures

Two dependent variables were chosen: gonorrhea testing and HIV testing. Respondents were asked, “In the past 12 months, how often have you been to a doctor, hospital, or clinic to get tested for gonorrhea?” A similarly phrased question assessed HIV testing in the past year. Responses to each item were recoded to represent either “no test in the previous year” or “any (gonorrhea or HIV) test in the previous year.”

STD-related stigma and STD-related shame were measured via items developed for the current research. A larger set of items was developed to assess personal reactions to STD and STD-related testing as well as perceptions of others' responses to these issues. Participants responded on a 5-point Likert scale ranging from strongly disagree to strongly agree. Pilot tests involving 100 volunteers were conducted to assess factor structure and scale reliability. Items that had factor loadings (i.e., correlations with their underlying factor) of .50 and contributed to overall scale reliability were retained. All factor cross loadings (i.e., correlations with nonunderlying factors) were less than .50. STD-related stigma (5 items; α = .77) reflected the participant's expectation of isolation and adverse social judgment associated with STD. STD-related shame (6 items; α = .80) reflected the participant's sense of shame and contamination associated with STD (Table 1).

Items in each scale were summed to create scale scores, with higher scores reflecting greater stigma or shame. The stigma and shame scales were moderately correlated (r = 0.54), suggesting that they measured separate but related constructs. Scale scores below the 75th percentile were reclassified as “low,” and scores above the 75th percentile were reclassified as “high.”

Additional predictor measures included sex, age (14–19, 20–29, 30–39, 40–49, or 50–59 years), enrollment site (community/health care facility), health service use in the past year (no/yes), and suspicion of gonorrhea in the past year (no/yes). These variables were selected to control for potential demographic differences in STD-related care seeking as well as influences of general use of health care or STD-related symptoms. With 2 exceptions, similar models were evaluated for each outcome. For gonorrhea testing, previous suspicion of gonorrhea was included to control for symptom-motivated care seeking. For HIV testing, receipt of a gonorrhea test in the past year was entered to control for routine HIV testing associated with STD-related visits.

Logistic regression (with 95% confidence intervals for each odds ratio) was used in conducting statistical analyses. Predictors were entered in a single block. Level of statistical significance was set at P < .05.

The original sample included 2020 individuals aged 12 to 83 years. Data on sex or age were missing for 10 participants, and these individuals were excluded from subsequent analyses. In addition, we restricted the sample to those aged 14 to 59 years to focus on the groups at greatest STD/HIV risk. The final sample included 1973 respondents (Table 2). Missing data reduced the available sample for some analyses. The majority of participants of both sexes were younger than 39 years. Sixty percent of the participants were enrolled from health care facilities.

There were no differences between male and female participants in regard to age or enrollment location (Table 2). Males were more likely than females to have suspected gonorrhea in the past, but females were more likely than males to have received a gonorrhea or HIV test in the past year. A significantly higher proportion of males were classified in the “high shame” group.

Multiple logistic regression analysis showed that gonorrhea testing was independently related to female sex, younger age, enrollment from a health facility, health service use in the past year, suspicion of gonorrhea, and low levels of STD-related stigma (Table 3). HIV testing was related to older age, health service use, gonorrhea testing, and low levels of STD-related stigma. STD-related shame was not related to gonorrhea testing or HIV testing.

We found that STD-related stigma was associated with a decreased likelihood of being tested for gonorrhea or HIV during the past year. This association was independent of other factors that may affect testing, such as sex, age, and suspicion of gonorrhea. STDrelated shame was not associated with receipt of STD-related care. This is not to say that negative emotions associated with STD/HIV-related care are an unimportant element of people's health care experiences.13 Rather, the perception that others confer negative attributes to those with STD is associated with less than optimal STD/HIV-related care.

Our findings are consistent with widely held assumptions about the role of stigma as a barrier to STD-related care. Our finding that stigma, rather than shame, may be a barrier to STD-related care seeking highlights the potential difficulties facing interventions designed to improve STD-related care seeking. Increasing knowledge or health care access may not address the barriers posed by STD-related stigma.4 Communitywide interventions, advocacy, and education might be expected to achieve some gains, although the (not uncommon) opinion that acknowledgment and discussion of issues such as STD/HIV prevention connote approval of proscribed sexual behaviors makes such approaches difficult to implement.14

Lay health advisors have been suggested as an excellent means for promotion of community norms of healthy sexuality and STDrelated care.15 However, a substantial body of social psychological research demonstrates the resistance to change of social stereotypes, especially in regard to conditions judged to be associated with irresponsible behavior.16 As long as at-risk people perceive adverse judgments associated with STD, stigma is likely to remain an important barrier to appropriate care.

Table
TABLE 1— Stigma and Shame Measures
TABLE 1— Stigma and Shame Measures
Stigma (α = .77)Shame (α = .80)
I would feel dirty if a doctor examined me for sexually transmitted diseasesPeople with sexually transmitted disease have been hanging with the wrong crowd
Getting a sexually transmitted disease would make me feel lonelyGetting a sexually transmitted disease means I don't keep myself clean
Getting examined for a sexually transmitted disease makes people think I have poor moralsPeople with sexually transmitted diseases should be ashamed of themselves
Most people I know think that a sexually transmitted disease is a sign of a weak characterGetting a sexually transmitted disease means a person is dirty
Getting a sexually transmitted disease means I have poor moralsGetting a sexually transmitted disease means I don't take care of myself
 Getting examined for a sexually transmitted disease means I'm not clean
Table
TABLE 2— Sample Characteristics, by Sex (n = 1973): Gonorrhea Community Action Project, 1998
TABLE 2— Sample Characteristics, by Sex (n = 1973): Gonorrhea Community Action Project, 1998
 Males (n = 847), No. (%)Females (n = 1126), No. (%)
Age, y  
    14–19281 (33)445 (40)
    20–29320 (38)402 (36)
    30–39167 (20)205 (18)
    40–49 60 (7) 57 (5)
    50–59 19 (2) 17 (2)
Previous suspicion of gonorrhea*  
    No541 (65)820 (74)
    Yes291 (35)290 (26)
Enrollment site  
    Community344 (41)448 (40)
    Health facility500 (59)675 (60)
Gonorrhea test, past year*  
    No422 (50)433 (39)
    Yes424 (50)693 (61)
HIV test, past year*  
    No322 (39)383 (35)
    Yes497 (61)714 (65)
STD-related stigma  
    Low621 (73)852 (76)
    High226 (27)274 (24)
STD-related shame*  
    Low546 (64)862 (77)
    High301 (36)264 (23)

Note. STD = sexually transmitted disease.

*P < .05 (for sex difference).

Table
TABLE 3— Predictors of Gonorrhea Testing or HIV Testing in the Past Year (Multiple Logistic Regression): Gonorrhea Community Action Project, 1998
TABLE 3— Predictors of Gonorrhea Testing or HIV Testing in the Past Year (Multiple Logistic Regression): Gonorrhea Community Action Project, 1998
 Gonorrhea Testing,aHIV Testing,b
 OR (95% CI)OR (95% CI)
Female (vs male)1.6 (1.3, 1.9)0.94 (0.75, 1.2)
Age (in decades)0.86 (0.78, 0.95)1.3 (1.1, 1.4)
Clinic (vs community)1.6 (1.3, 2.0)1.2 (0.99, 1.5)
Health service use, past year (vs no use)2.5 (2.0, 3.2)1.6 (1.2, 2.0)
Gonorrhea history (vs no history)2.3 (1.9, 2.9). . .
Gonorrhea test, past year (vs no test). . .8.5 (6.8, 10.6)
High stigma (vs low)0.77 (0.67, 0.97)0.66 (0.51, 0.86)
High shame (vs low)1.1 (0.90, 1.4)1.2 (0.92, 1.6)

Note. OR = odds ratio; CI = confidence interval.

aSample for logistic regression was 1929 owing to listwise deletion of missing data; model χ2 = 190.0; P < .05.

bSample for logistic regression was 1903 owing to listwise deletion of missing data; model χ2 = 501.2; P < .05.

This research was sponsored by the Centers for Disease Control and Prevention and the National Institute of Mental Health. Portions of the research were presented at the meeting of the Society for Adolescent Medicine, March 2000, Arlington, Va.

References

1. Stall R, Hoff C, Coates TJ, et al. Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: implications for secondary prevention efforts. J Acquir Immune Defic Syndr Hum Retrovirol.1996;11:151–160. Crossref, MedlineGoogle Scholar
2. Boyd FM, Simpson WM, Hart GJ, Johnstone FD, Goldberg DJ. What do pregnant women think about the HIV test? A qualitative study. AIDS Care.1999;11:21–29. Crossref, MedlineGoogle Scholar
3. Simpson WM, Johnstone FD, Goldberg DJ, Gormley SM, Hart GJ. Antenatal HIV testing: assessment of a routine voluntary approach. BMJ.1999;318:1660–1661. Crossref, MedlineGoogle Scholar
4. Woods WJ, Dilley JW, Lihatsh T, Sabatino J, Adler B, Rinaldi J. Name-based reporting of HIV-positive test results as a deterrent to testing. Am J Public Health.1999;89:1097–1100. LinkGoogle Scholar
5. The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Washington, DC: National Academy Press; 1997. Google Scholar
6. Lewis M. Shame and stigma. In: Gilbert P, Andrews B, eds. Shame: Interpersonal Behavior, Psychopathology, and Culture. New York, NY: Oxford University Press Inc; 1999:126–140. Google Scholar
7. Corrigan PW, Penn DL. Lessons from social psychology on discrediting psychiatric stigma. Am Psychol.1999;54:765–776. Crossref, MedlineGoogle Scholar
8. Herek GM, Mitnick L, Burris S, et al. AIDS and stigma: a conceptual framework and research agenda. AIDS Public Policy J.1998;13:36–47. MedlineGoogle Scholar
9. Link BG, Phelan JC. Labeling and stigma. In: Aneshensel CS, Phelan JC, eds. Handbook of the Sociology of Mental Health. New York, NY: Kluwer Academic/Plenum Publishers; 1999:481–494. Google Scholar
10. Tangney JP, Miller RS, Flicker L, Barlow DH. Are shame, guilt, and embarrassment distinct emotions? J Pers Soc Psychol.1996;70:1256–1269. Crossref, MedlineGoogle Scholar
11. Oxman AD, Scott EA, Sellors JW, et al. Partner notification for sexually transmitted diseases: an overview of the evidence. Can J Public Health.1994;85(suppl 1):S41–S47. MedlineGoogle Scholar
12. Wenger NS, Linn LS, Epstein M, Shapiro MF. Reduction of high-risk sexual behavior among heterosexuals undergoing HIV antibody testing: a randomized clinical trial. Am J Public Health.1991;81:1580–1585. LinkGoogle Scholar
13. Holgate HS, Longman C. Some people's psychological experiences of attending a sexual health clinic and having a sexually transmitted infection. J R Soc Health.1998;118:94–96. Crossref, MedlineGoogle Scholar
14. DiClemente RJ. Preventing sexually transmitted infections among adolescents: a clash of ideology and science. JAMA.1998;279:1574–1575. Crossref, MedlineGoogle Scholar
15. Thomas JC, Eng E, Clark M, Robinson J, Blumenthal C. Lay health advisors: sexually transmitted disease prevention through community involvement. Am J Public Health.1998;88:1252–1253. MedlineGoogle Scholar
16. Weiner B. Judgments of Responsibility: A Foundation for a Theory of Social Conduct. New York, NY: Guilford Press; 1995. Google Scholar

Related

No related items

TOOLS

SHARE

ARTICLE CITATION

J. Dennis Fortenberry, MD, MS, Mary McFarlane, PhD, Amy Bleakley, MPH, Sheana Bull, PhD, Martin Fishbein, PhD, Diane M. Grimley, PhD, C. Kevin Malotte, DrPH, and Bradley P. Stoner, MD, PhDJ. Dennis Fortenberry is with the Section of Adolescent Medicine, Indiana University School of Medicine, Indianapolis. Mary McFarlane is with the Behavioral Interventions Research Branch, Centers for Disease Control and Prevention, Atlanta, Ga. Amy Bleakley is with the Mailman School of Public Health, Columbia University, New York, NY. Sheana Bull is with the AMC Cancer Research Center, Denver, Colo. Martin Fishbein is with the Annenberg School of Communications, University of Pennsylvania, Philadelphia. Diane M. Grimley is with the Department of Health Behavior, School of Public Health, University of Alabama at Birmingham. C. Kevin Malotte is with the Health Science Department, California State University, Long Beach. Bradley P. Stoner is with the Department of Anthropology, Washington University School of Medicine, St. Louis, Mo. “Relationships of Stigma and Shame to Gonorrhea and HIV Screening”, American Journal of Public Health 92, no. 3 (March 1, 2002): pp. 378-381.

https://doi.org/10.2105/AJPH.92.3.378

PMID: 11867314